← board
RLFTY
distress 5/10 · elevated risk$0.420%today-90% from 52w high
Revenue
pre-revenue
Liquidity
$9M
Runway
1.3 yrs
Shares 1y
-100%
Price & events
-89.6% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+0.0%
1W
+0.0%
1M
-82.4%
3M
-89.6%
6M
—
1Y
—
2Y
—
5Y
-71.8%
All
Overview
- Market Cap
- $5.30M
- Volume
- 0
- 52 Week Range
- $0.27 – $4.05
- Total Shares
- 12.54M
- Float Shares
- 37.20M
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.